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Background: The Structured Migraine Interview (SMI) is a valid and reliable instrument for migraine diagnosis.
However, a Malay version of the SMI is not available to be applied to the local Malaysian population. This study was
designed to access the validity and reliability of a new Malay version of the SMI questionnaire.
Methods: Patients with headache attending the Neurology Clinic, Hospital Universiti Sains Malaysia, Kelantan,
Malaysia, were screened against the inclusion/exclusion criteria before recruitment. A standard translation procedure
was used to translate and adapt the questionnaire into the Malay language. The translated version was tested for
face, content and construct validities. Subsequently, validity and reliability studies were conducted (1st compilation),
followed by retesting seven days later (2nd compilation).
Results: A total of 157 patients between 15 and 60 years of age were enrolled in this study. The kappa value was
0.70 (p < 0.001) with high sensitivity (0.97) and specificity (0.63). The misclassification rate was 0.15, with a positive
predictive value of 0.82 and a negative predictive value of 0.92. The positive likelihood ratio was 2.62, while the
negative likelihood ratio was 0.05. The Cronbach’s alpha was 0.93 (1st compilation) and 0.90 (2nd compilation),
respectively. The Spearman’s correlation coefficient ranged from 0.86 (Question 4) to 0.95 (Question 1). The overall
concordance for item 1 was very high (97%), followed by item 4 (83%), item 2 (71%) and finally item 3 (64%).
Conclusion: The Malay version of the SMI questionnaire is comparable to the English version in terms of validity
and reliability. It was highly reliable with good internal consistency and can be used for the diagnosis of migraine
in clinical settings in Malaysia.
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Migraine is a common, painful and disabling condition
characterized by recurrent, unilateral and pulsatile
attacks of headaches of moderate or severe intensity
[1]. Most migraine attacks begin at puberty and
affect those between 35 and 45 years of age. The
prevalence of migraine among women is higher (5%
to 25%) when compared with men (only 2% to 10%)
[2,3]. The prevalence peaks in the middle age but
was reported to be lower in adolescents and among
the elderly (older than 60 years of age) [3].
According to the International Headache Society (IHS)
diagnostic criteria, migraine can be divided into two sub-
types: migraine with aura (MA) and migraine without* Correspondence: shgan@usm.my
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reproduction in any medium, provided the origaura (MO), with the latter being the more common type
(80%) [3]. MA presents with reversible symptoms such
as blurred vision, vertigo or hallucinations that precede
or accompany the headache. This situation is different
from MO in which such symptoms are absent [4].
Nearly 31% of migraine populations are reported to have
attack frequencies of three or more per month, with 54%
reporting severe impairment [3]. Disability due to recur-
rent headache is a major concern in migraine patients
because it impairs quality of life (QOL) and work cap-
acity [5]. The World Health Organization reported that
migraine is ranked as the 19th cause of years living with
disability [6].
Surprisingly, nearly 60% of migraine sufferers are
unaware that they have migraine [7]. Furthermore, the
diagnosis of migraine tends to be limited to a smaller
population due to the lack of proper healthcare,is is an Open Access article distributed under the terms of the Creative
mmons.org/licenses/by/4.0), which permits unrestricted use, distribution, and
inal work is properly credited.
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may contribute to the delay in providing treatment
and may affect migraine patients’ QOL and duration
of quality working hours. Accordingly, migraine may
become a burden to the patient and to the patient’s
family members, as well as to the country, either dir-
ectly or indirectly.
A migraine diagnosis is important because it reduces
the burden of symptoms on patients and improves the
prognosis for migraine and its associated psychiatric co-
morbidities. However, migraine screening among the
general population is seldom conducted due to lack of
awareness and proper tools. Because there are no known
biological markers identified for the objective assessment
of migraine, migraine diagnosis currently relies solely on
careful history documentation and on the absence of sig-
nificant signs upon physical examination.
The IHS published diagnostic criteria for all types of
headache disorders including migraine [8], which can
assist clinicians to diagnose migraine in a systematic man-
ner. However, subjective diagnosis may lead to inaccur-
acies, as diagnoses may vary from one clinician to
another. Therefore, to avoid inconsistency and lack of
agreement between clinicians, a structured and reliable
method to define clinical symptoms and phenotypes such
as depression and headache is very important to improve
diagnostic accuracy.
Several questionnaires are available for the diagnoses
of migraine including ID-Migraine Screener (IDMS) [9],
deCODE Migraine Questionnaire (DMQ3) [10], the
Dutch headache questionnaire [11] and the German
headache questionnaire [12]. The most popular ques-
tionnaire (IDMS) has only three items, but it fails to
identify the aura symptoms. In addition, this question-
naire is limited only to the clinical diagnosis and may
not be useful for genetic research [9]. The DMQ3 ques-
tionnaire can be useful in diagnosing both MA and MO.
However, it contains 56 items, which can be tedious for
the patients to answer [10]. In addition, the Dutch and
German headache questionnaires are not preferred be-
cause of their poor sensitivity among patients [11,12]. In
comparison, the Structured Migraine Interview (SMI)
Questionnaire [13] is a simple self-administered ques-
tionnaire that can diagnose migraine according to the
guidelines of the IHS and was therefore selected for this
study.
The SMI questionnaire was designed to determine
whether a patient has suffered from migraine at any time
in his/her life [13]. The questions were designed to in-
clude individual items from the International Classifica-
tion of Headache Disorders (ICHD) criteria for migraine
[4]. This instrument consisted of two sections; the first
consisted of four items for migraine diagnosis, and the
second contained six items for screening of symptomsassociated with migraine. The diagnosis of MA is based
on having the diagnostic features of MO and must in-
clude at least five migraine attacks in one’s lifetime. In
addition, for the diagnosis of MA, there must be at least
two attacks accompanied by aura symptoms as deter-
mined by question 4.
To date, there is no Malay version of SMI for use in
the local setting. For accurate and reliable responses and
for greater relevance to the local setting, a questionnaire
in the National Malay language is required for the diag-
nosis of migraine. Therefore, this study aimed to develop
and validate a new Malay-translated version of the SMI
to be applied to the local population of migraine
sufferers.
Methods
The translation of the original English SMI version into
the Malay version was conducted according to a stan-
dardized protocol [14] (Figure 1). Only the first part of
the original SMI was translated and validated in this
study.
Forward and back translations
Two independent translators (NNI and ZZ) performed
the forward translations. Both translators are native
Malay speakers with a good command of English who
speak multiple dialects of the Malay language and are
bicultural. The forward translated versions were evalu-
ated by a panel of experts (NBH, SHG and SB) to fur-
ther verify the conceptual, idiomatic, semantic, and
cross-cultural equivalence to the English version.
The final forward translation was then back-translated
into the English language by two different independent
back-translators (AFAR and AHA). Both translators
were unaware of the concepts and purpose of the ques-
tionnaire or the nature of the study. These translators
were bicultural, native Malay speakers with multiple dia-
lects and with good command of the English language.
A special panel (NBH and SHG) reviewed the forward-
and back-translated versions to produce the final draft of
the Malay version of the SMI-M.
Face and content validity of the SMI-M
To determine face validity, the SMI-M was administered
to 30 patients who have headache and are aged between
15 and 60 years. This step is essential to ensure the quality
of the questionnaire and also to acquire proper feedback
from patients when answering the translated questions,
especially in understanding the medical terminology used.
During this period, no difficulties in understanding the
questions were noted. Overall, the SMI-M questionnaire
was easily understood and well accepted by both the pa-
tients and the experts alike. The content validity was then
established by administering the SMI-M questionnaire to
NNI: Nik Nor Izah Nik Ibrahim, ZZ: Zalina Zahari, AFAR: Abdul Fatah Abdul Rahman, AHA: Asma Hayati Ahmad, NBH: Norul Badriah Hasan, SHG: Siew HuaGan, SB: Shalini Bhaskar
English version
of SMI-M
Review of forward & back 
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Back translation
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Forward translation
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Back translation
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Figure 1 Forward and back translations of the SMI-M Questionnaire.
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evaluation. A special panel (NHB, SHG and SB) further
reviewed, discussed and modified the questionnaire based
on the noted problems to construct the final SMI-M
questionnaire.
Data collection
Patients with headache (n = 200) who registered with the
Neurology Clinic of Hospital Universiti Sains Malaysia
(HUSM) between January and December 2013 were ran-
domly screened according to the inclusion and exclusion
criteria. The inclusion criteria included patients ageing
between 15 and 60 years who have been diagnosed with
migraine based on the criteria of the 2nd edition of the
ICHD (ICHD-II), 2004 [1] or who are suspected to be
suffering from headache. Patients with cardiovascular
disorders, neurological disorders, head injuries, ophthal-
mological problems, menstrual migraine or who were
pregnant were excluded. The study was approved by the
Universiti Sains Malaysia Research and Ethical commit-
tee (ethical no: USMKK/PPP/JEPeM [231.3.(08)]) and
complies with the Declaration of Helsinki.
After the initial screening process, 157 patients having
headache agreed to participate in the study (Figure 2).
They were verbally informed about the purpose of the
study before being asked to complete the written in-
formed consent forms, basic socio-demographic infor-
mation form and SMI-M questionnaire. Following this
step, all patients were evaluated by a headache specialist
during their initial visits. Overall, patients were asked to
complete the SMI-M twice: the first time during their
visits to the clinic (1st compilation) and the second time
at home (2nd compilation) where the completed SMI-M
questionnaires were mailed back to researchers in
standard stamped envelopes seven days following thecompletion of the 1st compilation. Patients were only
aware of their clinical diagnosis but not the diagnosis
by SMI-M. In addition, patients were also asked to con-
tinue their regular medication if prescribed by the
clinician.
Statistical analysis
Kaiser-Meyer-Olkin (KMO) and the Barlett’s tests of
sphericity were applied to estimate the sampling ad-
equacy [15]. Sensitivity, specificity, misclassification rate,
positive predictive value, negative predictive value, posi-
tive likelihood ratio and negative likelihood ratio of mi-
graine diagnosis by SMI-M were further measured to
test the validity of the SMI-M.
The internal consistency of the SMI-M score was
assessed using Cronbach’s alpha (α). An α value of 0.7 is
considered to be “acceptable”, while an α value of 0.8 or
more indicates excellent internal consistency [16]. A
test-retest reliability to measure consistency across the
duration (i.e., between the 1st and 2nd compilations) of
both total and individual question scores was evaluated
using Spearman correlations. A Spearman correlation is
conservative, as it is not usually influenced by outliers.
The percentage of concordance of the 2nd compilation
compared with the 1st was taken as the stability of the
SMI-M. Statistical analysis was conducted using SPSS
version 20.0 software (New York, USA).
Results
Validity and reliability of the SMI-M
A total of 157 patients with headache completed the ad-
ministered questionnaires relatively quickly. None of the
patients had any difficulties understanding or answering
any parts of the SMI-M. The mean age of the patients
was 26.81 (8.33) years and the number of years of
Table 1 Demographicdata of the subjects
n (157) Percentage (%) Mean SD
Age (years) 26.81 8.33
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Above 6000 9 5.7
MYR: Malaysian ringgit.
SMI-M: Malay-translated version of Structured Migraine Interview
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Figure 2 Flowchart of data collection.
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majority of the patients were students (56.7%) and sin-
gletons (70.7%). The majority (63.7%) of household in-
comes were average (between RM 801- RM 3000).
Only female patients were recruited for the study, and
all of them were of the Malay race, which is the dom-
inant ethnic group in the Kelantan state of Malaysia.
The sample was adequate as indicated by a KMO
value of 0.85 and a significant Barlett’s test of spher-
icity (p < 0.001).
Clinically, 63.7% of the patients were diagnosed as hav-
ing migraine by the neurologist (SB) in contrast to 75.2%
diagnosed as having migraine using the SMI-M ques-
tionnaire (Figure 3). In total, 22.9% of the patients were
diagnosed as not having migraine by both the neurolo-
gist and the SMI-M questionnaire. However, 13.4% of
the patients were diagnosed as having migraine using
the SMI-M, and these same patients were diagnosed as
not having migraine by the neurologist. The SMI-M
failed to accurately diagnose three (1.9%) patients as
having migraine as diagnosed by the neurologist. There-
fore, the misclassification rate was 0.15, the positive pre-
dictive value was 0.82, the negative predictive value was
0.92, the positive likelihood ratio was 2.62, and the nega-
tive likelihood ratio was 0.05. In addition, the sensitivity
was 0.97 and specificity was 0.63. The Kappa statistic
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Figure 3 Comparison of SMI-M and clinical diagnosis.






Migraine 97 (a) 21 (b) 118
No migraine 3 (c) 36 (d) 39
Total 100 57 157
Note: Sensitivity: a/(a + c) = 97 / (97 + 3) = 0.97.
Specificity: d/(b + d) = 36 / (36 = 15) = 0.63.
Misclassification rate: (b + c) / (a + b + c + d) = (21 + 3)/(97 + 21 + 3 + 36) = 0.15.
Positive predictive value: a/(a + b) = 97/(97 + 21) = 0.82.
Negative predictive value: d/(c + d) = 36 /(36 + 3) =0.92.
Positive likelihood ratio: Sensitivity / (1-specificity) = 0.97 / (1-0.63) = 2.62.
Negative likelihood ratio: (1-Sensitivity) / specificity = (1-0.97) / 0.63 = 0.048.
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pilations (0.90, p < 0.001) exceeded the 0.9 level, indi-
cating excellent internal consistency. The Spearman’s
correlations for the 1st and 2nd compilations were com-
pared and ranged from 0.86 (for question 4) to 0.95
(for question 1) (Table 3). The overall concordance was
calculated as the percentage of the 1st and 2nd compila-
tions for each item (Table 4). The overall concordance
for item 1 was very high (97%), followed by item 4
(83%), item 2 (71%) and item 3 (64%). For item 2 (mod-
erate to severe headache accompanied by nausea and/
or vomiting), approximately 85.71% of the patients
changed their responses from the fourth option (Yes,
10+ times) to other options. For item 3 (moderate to
severe headache accompanied by hypersensitivity to
sound or light), approximately73.91% of the patients
changed their responses from the fourth option (Yes,
10+ times) to other options.Discussion
In this study, we successfully developed and validated
the SMI-M questionnaire, which is suitable to be ap-
plied to the local population. The present study indi-
cated that the translated version of the SMI-M
questionnaire was valid, reliable and could easily be
applied for migraine diagnosis. It is also easy to
understood and well accepted by patients with head-
ache. The factor analysis with a good KMO value and
a significant Barlett’s test of sphericity, indicated that
there was an adequate sample size for the validation
of the SMI-M questionnaire. The patients recruit-
ment, study design and validation of SMI-M were
similar with the original study in order to eliminate
the bias when comparing the findings of both studies.
To our knowledge, our study is the first migraine
diagnostic study conducted in the South East Asia
region.




1. Have you ever had recurrent headaches? [Pernahkah anda mengalami sakit kepala yang berulang-ulang?] 0.95 <0.001
2. Have you ever had moderate to severe headache accompanied by nausea and/or vomiting? [Pernahkah
anda mengalami sakit kepala yang sederhana hingga teruk yang disertai rasa loya dan/atau muntah?]
0.87 <0.001
3. Have you ever had moderate to severe headache accompanied by hypersensitivity to sound or light?
[Pernahkah anda mengalami sakit kepala yang sederhana hingga teruk yang disertai dengan
hipersensitiviti kepada bunyi atau cahaya?]
0.88 <0.001
4. Have you ever had visual disturbances e.g., (Flashing lights, zigzag lines, blurred vision) Lasting
5-60 minutes followed by headache? [Pernahkah anda mengalami gangguan penglihatan contohnya
(cahaya yang berkelip-kelip, garisan yang berbentuk zigzag, penglihatan yang kabur) berlanjutan selama
5 hingga 60 minit dan diikuti dengan sakit kepala?]
0.86 <0.001
*Correlation was significant at 0.05 level.
SMI-M: Malay-translated version of Structured Migraine Interview.
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Patients attending a neurology clinic are usually afflicted
with severe headache associated with impairment so de-
bilitating that a specialist’s intervention is required. Dur-
ing the 1st compilation, patients were asked to report
any problems related to the questionnaire. However, no
difficulties in understanding and answering the SMI-M
questionnaire were reported. In addition, no ongoing
therapies (symptomatic or prophylactic) undertaken by
the patients were altered during the course of the test-
retest study to ensure that similar conditions were main-
tained for the patients in both compilations.
Migraine remains a clinical diagnosis based on the
IHS’ migraine diagnosis criteria, which is considered to
be the “gold standard”. Therefore, the findings from the
SMI-M were compared with migraine diagnosis by the
headache specialist in order to test the validity of SMI-
M. The validity testing compared with the clinical diag-
nosis indicated that the SMI-M is a highly sensitive
(0.97) instrument but was only moderately specific
(0.63) in identifying migraine cases. Nevertheless, the
sensitivity and specificity results of the SMI-M from this
study were consistent with the original questionnaire.
The moderate value of kappa statistic (0.7) indicates a
substantial agreement between SMI-M and the clinical
diagnosis [17]. The kappa value in this study was slightly
lower (0.70) than that in the original study (0.82). Previ-
ous reports suggested that regional differences may lead
to variations in the clinical diagnosis. The difference in
the kappa values between the original SMI and SMI-M
may be due to differences in clinical practices between
clinicians in the different regions [18]. Furthermore, var-
iations between personal, organizational and systemic
levels may also lead to variations in clinical practice [19].
The positive predictive value (0.82) was slightly lower
than that of the original study (0.97). However, the posi-
tive predictive value depends upon the prevalence of theoutcome of interest, which varies from one population
to another [20]. Nevertheless, the negative predictive
value in this study (0.92) was much higher than that of
the original study (0.26), indicating that the SMI-M
questionnaire rarely misclassified a migraine patient as a
non-migraine patient [20].
The lower misclassification rate (0.15) indicates that
SMI-M is not capable of labelling non-migraine patients
as having migraine. A higher positive likelihood ratio of
SMI-M (2.62) in this study when compared with the ori-
ginal SMI (2.07) suggested that there was a higher prob-
ability for a migraine patient to be correctly diagnosed
using this questionnaire. A lower negative likelihood ra-
tio of SMI-M (0.05) than the original SMI (0.22) makes
SMI-M optimal in ruling out the chances of wrongly
diagnosing migraine. Therefore, the SMI-M can help clini-
cians to decide whether a patient indeed has migraine [21].
The SMI-M has been reported to be comparable with
the IDMS [9] and DMQ3 [10] but is better than the
Dutch [11] and German headache questionnaires [12],
which was also found in our study. For example, the
sensitivity of SMI-M (0.97) was similar to that of the
DMQ3 (0.99) but was higher than those of the IDMS
(0.81), Dutch (0.51) and German headache question-
naires (0.63). In comparison with SMI-M, the DMQ3
contained 56 items, which can be tedious for patients to
answer. In contrast, the SMI-M is very easy for patients
to score when compared with the DMQ3, as it has only
four items focusing specifically on migraine diagnosis.
However, the IDMS questionnaire only has three items
but does not contain any questions related to aura
symptoms. Therefore, the SMI-M is a valid tool to be
used in research for the identification of migraine in
large samples where clinical interviews are less practical.
In addition, the SMI-M should be applied to the local
clinical settings for reconfirming the status of migraine.
Nevertheless, some variations (whenever they exist) may
Table 4 Changes of the SMI-M items response from the 1st and 2nd compilations
Q1. Have you ever had recurrent headaches?
Number and percentage of
patients for each response
at first compilation
Number and percentage of
patients for each response at
second compilation
Number and percentage of
patients who changed grades
between administrations
No Yes
No 32 (20.4%) 32 (100.0%) 0 (0.0%) 0 (0.0%)
Yes 125 (79.6%) 3 (2.4%) 122 (97.6%) 3 (100%)
Total 157 (100.0%) 35 (22.3%) 122 (77.7%) 3 (1.9%)
Q2. Have you ever had moderate to severe headache accompanied by nausea and/or vomiting?
Number and percentage of
patients for each response
at first compilation
Number and percentage of
patients for each response at
second compilation
Number and percentage of
patients who changed grades
between administrations
No, Never Yes, 1-4 times Yes, 5-9 times Yes, 10+ times
No, Never 32 (20.4%) 31 (96.9%) 1 (3.1%) 0 (0.0%) 0 (0.0%) 1 (3.4%)
Yes, 1-4 times 94 (59.9%) 3 (3.2%) 82 (87.2%) 8 (8.5%) 1 (1.1%) 12 (41.4%)
Yes, 5-9 times 17 (10.8%) 0 (0.0%) 4 (23.5%) 13 (76.5%) 0 (0.0%) 4 (13.8%)
Yes, 10+ times 14 (8.9%) 0 (0.0%) 1 (7.1%) 11 (78.6%) 2 (14.3%) 12 (41.4%)
Total 157 (100.0%) 34 (21.7%) 88 (56.1%) 32 (20.4%) 3 (1.9%) 29 (18.5%)
Q2. Have you ever had moderate to severe headache accompanied by hypersensitivity to sound or light?
Number and percentage of
patients for each response
at first compilation
Number and percentage of
patients for each response at
second compilation
Number and percentage of
patients who changed grades
between administrations
No, Never Yes, 1-4 times Yes, 5-9 times Yes, 10+ times
No, Never 45 (28.7%) 38 (84.4%) 7 (15.6%) 0 (0.0%) 0 (0.0%) 7 (19.4%)
Yes, 1-4 times 72 (45.9%) 3 (4.2%) 64 (88.9%) 5 (6.9%) 0 (0.0%) 8 (22.2%)
Yes, 5-9 times 17 (10.8%) 0 (0.0%) 3 (17.6%) 13 (76.5%) 1 (5.9%) 4 (11.1%)
Yes, 10+ times 23 (14.6%) 0 (0.0%) 2 (8.7%) 15 (65.2%) 6 (26.1%) 17 (47.2%)
Total 157 (100.0%) 41 (26.1%) 76 (48.4%) 33 (21.0%) 7 (4.5%) 36 (22.9%)
Q4. Have you ever had visual disturbances e.g., (flashing lights, zigzag lines, blurred vision) lasting5-60 minutes followed by headache?
Number and percentage of
patients for each response
at first compilation
Number and percentage of
patients for each response at
second compilation
Number and percentage of
patients who changed grades
between administrations
No, Never Yes, once Yes, 2+ times
No, Never 52 (33.1%) 49 (94.2%) 1 (1.9%) 2 (3.8%) 3 (17.7%)
Yes, once 51 (32.5%) 4 (7.8%) 46 (90.2%) 1 (2.0%) 5 (29.4%)
Yes, 2+ times 54 (34.4%) 2 (3.7%) 9 (16.7%) 43 (79.6%) 9 (52.9%)
Total 157 (100.0%) 41 (26.1%) 76 (48.4%) 33 (21.0%) 17 (10.8%)
SMI-M: Malay-translated version of Structured Migraine Interview.
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the degree of strictness with which the ICHD-II criteria
were applied in clinical the diagnosis.
Reliability of SMI-M questionnaire
The internal consistency of the SMI-M questionnaire
was excellent for both compilations. The higher value of
Cronbach’s alpha indicated a higher degree to which all
items in the SMI-M questionnaire measured single uni
dimensional latent constructs. This value also indicated
good questionnaire reliability in diagnosing migraine
among Malay patients with headache. Although thepatients were aware of their neurological diagnosis, the
high correlation values based on Spearman’s statistical
analysis indicated excellent test-retest reliability seen
with the SMI-M questionnaire. In this study, comparing
the reliability of the SMI-M with the original SMI ques-
tionnaire could not be conducted, as reliability studies
were not reported in the original study.
Among all of the items, item 1 yielded the highest
Spearman’s correlation, which may be attributed to the
simplicity of the question pertaining to the existence of
recurrent headache. However, item 4 yielded the lowest
Spearman’s correlation coefficient, even though the
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be attributed to the 7 days gap, which may have allowed
some time for the development of migraine-related
events that may have affected some of the responses in-
cluding MA symptoms in between the two compilations.
Nearly 36% of the patients changed their response
choice from the 1st to the 2nd compilation, which again
may be attributed to the 7 day gap between the compila-
tions. It was observed that the change of symptoms or a
new migraine attack could occur in a short period,
which may be sustained for long hours and may contrib-
ute to the change in scores in a short time period espe-
cially among severe migraine patients. For item 1, only
3% of the patients changed their responses, but for item
3, 36% patients changed their responses between both
compilations. The duration between both compilations
may have allowed precipitations or changes in the symp-
toms, especially if patients are hypersensitive to light
and sounds, which are common stimulants for migraine
as investigated in question 3. Nevertheless, gaps between
2 days and two weeks have previously been reported to
be ideal for test-retest reliability studies [22].
The second part of the original SMI questionnaire that
was related to symptoms was not included in the SMI-
M as it is simpler, less time consuming, and focuses only
on diagnosis. Moreover, removing the second part of the
questionnaire did not affect its validity or reliability.
Limitations of the study
This sample was limited only to patients from the Malay
race because there was no report of migraine patients
from other races (Chinese, Indian and Siamese). All pa-
tients were females because no male patients with head-
ache visited the clinic during the study period. Although
care was taken with the translation and cross-cultural
adaptation process to keep the originality, simplicity and
clarity of the questionnaire, cross-cultural equivalence of
the questionnaire is subjective and is difficult to measure
precisely. Therefore, expert judgment was necessary to
investigate whether the original and translated versions
are equal.
Conclusions
In conclusion, the SMI-M questionnaire maintains the
conciseness and validity parameters of the English ver-
sion, but is simpler and less time consuming. The reli-
ability values of SMI-M were also exceptionally good,
with a high concordance percentage between the 1st and
2nd administrations of the SMI-M. Therefore, the SMI-
M is a good and useful self-assessment tool for theearly
diagnosis of individuals with migraine.
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